Carbohydrate-based Adjuvants Activate Tumor-Specific Th1 and CD8 T-cell Responses and Reduce the immunosuppressive Activity of MDSCs

Carbohydrate-based Adjuvants Activate Tumor-Specific Th1 and CD8 T-cell Responses and Reduce the immunosuppressive Activity of MDSCs